(pressebox) (Ingelfingen-Criesbach, 10.03.2020) The GEMÜ globe valves 507, 550 and 554 with stainless steel valve bodies and PTFE seals from the valve specialist GEMÜ have been awarded approval in accordance with USP Class VI. They now comply with the prerequisites for application in the medical and pharmaceutical industries.

The U.S. Food and Drug Administration (FDA) divides the plastics used in the medical and pharmaceutical industries into six biocompatibility classes in the American Drugs and Medicines Register (USP). The most stringent of the six categories is the USP Class VI classification. It is the prerequisite for use of the materials in the medical and pharmaceutical industries.

With immediate effect, the GEMÜ globe valves 507, 550 and 554 with PTFE gland packing (GEMÜ code 5P) and stainless steel valve bodies (GEMÜ code 37, 34 or C2) now have certification in accordance with USP Class VI and are therefore approved for use in the medical and pharmaceutical industries.

Über GEMÜ Gebr. Müller Apparatebau GmbH & Co. KG: The GEMÜ Group develops and manufactures valves, measurement and control systems for liquids, vapours and gases. GEMÜ is a global market leader when it comes to solutions for sterile applications.

The globally focused, independent family-owned enterprise was founded in 1964. In 2011, Gert Müller took over as Managing Partner together with his cousin Stephan Müller, becoming the second generation to run the company. The Group achieved a turnover of over €330 million in 2019 and currently employs over 1900 members of staff worldwide, over 1100 of whom are in Germany. They have six manufacturing locations: Germany, Switzerland and France, as well as China, Brazil and the USA. Their worldwide marketing is carried out across 27 subsidiaries, coordinated from Germany. Thanks to a large network of commercial partners, GEMÜ is now active in over 50 countries on all continents.

Please visit www.gemu-group.com for further information.